Publications by authors named "Adam L Knight"

Claim this Profile
R
Roles of H3K27me2 and H3K27me3 Examined during Fate Specification of Embryonic Stem Cells.
Aster H Juan, Stan Wang, Kyung Dae Ko, Hossein Zare, Pei-Fang Tsai, Adam L Knight

Cell Rep· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roles of H3K27me2 and H3K27me3 Examined during Fate Specification of Embryonic Stem Cells.
Aster H Juan, Stan Wang, Kyung Dae Ko, Hossein Zare, Pei-Fang Tsai, Adam L Knight

Cell Rep· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of mitochondrial transport in neurons.
Bing Zhou, Mei-Yao Lin, Tao Sun, Adam L Knight, Zu-Hang Sheng

Methods Enzymol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The glycolytic enzyme, GPI, is a functionally conserved modifier of dopaminergic neurodegeneration in Parkinson's models.
Adam L Knight, Xiaohui Yan, Shusei Hamamichi, Rami R Ajjuri, Joseph R Mazzulli

Cell Metab· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans.
Julia Bornhorst, Sudipta Chakraborty, Sören Meyer, Hanna Lohren, Sigrid Grosse Brinkhaus, Adam L Knight

Metallomics· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel ATP13A2 interactors and their role in α-synuclein misfolding and toxicity.
Marija Usenovic, Adam L Knight, Arpita Ray, Victoria Wong, Kevin R Brown

Hum Mol Genet· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies.
Joseph R Mazzulli, You-Hai Xu, Ying Sun, Adam L Knight, Pamela J McLean

Cell· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caenorhabditis elegans as a model system for identifying effectors of α-synuclein misfolding and dopaminergic cell death associated with Parkinson's disease.
Adam J Harrington, Adam L Knight, Guy A Caldwell, Kim A Caldwell

Methods· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reprogramming Parkinson's disease research.
Adam L Knight, J Gavin Daigle

Dis Model Mech· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of stable transgenic C. elegans using microinjection.
Laura A Berkowitz, Adam L Knight, Guy A Caldwell, Kim A Caldwell

J Vis Exp· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes.
Laura A Berkowitz, Shusei Hamamichi, Adam L Knight, Adam J Harrington, Guy A Caldwell

J Vis Exp· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model.
Shusei Hamamichi, Renee N Rivas, Adam L Knight, Songsong Cao, Kim A Caldwell

Proc Natl Acad Sci U S A· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis